3 news items
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
AGRI
ALLO
BDRX
21 May 24
Materials Inc. (NASDAQ:MMAT) gained 59.1% to $3.66 in pre-market trading
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich's Ataxia
LRMR
20 May 24
to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
LRMR
9 May 24
involve risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from
- Prev
- 1
- Next